文献速递瓣膜外科先天性心脏病外科

去细胞同种瓣膜残留免疫反应或具高度个体差异

Residual immune response towards decellularized homografts may be highly individual.
PubMed 文献 · Eur J Cardiothorac Surg · 2021-01-01

本研究建立半定量斑点印迹法,筛查15个去细胞同种瓣膜(7个主动脉瓣、8个肺动脉瓣)与20名健康对照血清中预存抗体的结合情况。年轻对照(18-25岁)抗体结合显著强于年长者(48-73岁),男性对肺动脉瓣抗体结合显著高于女性,ABO血型不合无影响。结论提示去细胞同种瓣膜虽几乎完全去除细胞,仍存在残留免疫原性,个体差异大,或可用于术前配型。

要点

  • 年轻健康对照血清预存抗体对去细胞同种瓣膜结合显著强于年长者。
  • 男性血清对肺动脉去细胞同种瓣膜抗体结合显著高于女性。
  • 斑点印迹法可半定量评估个体对去细胞同种瓣膜的免疫反应。

核心结论

  • 去细胞同种瓣膜几乎完全去除细胞后仍存在残留免疫原性,且个体间差异高度显著。

研究设计与样本

  • 建立半定量斑点印迹法,用抗人二抗筛查预存抗体;15个去细胞同种瓣膜样本(7个主动脉瓣、8个肺动脉瓣)溶解后与20名健康对照血清反应。

主要发现

  • 年轻对照(n=10,18-25岁)血清预存抗体结合显著强于年长对照(n=10,48-73岁),任意单位均值差15.1±6.5(P=0.0315)。
  • 个体内抗体结合量差异大,部分健康对照对2个不同去细胞同种瓣膜的抗体结合高于其他对照10倍以上。
  • 主动脉瓣去细胞同种瓣膜结合预存抗体均值17.2±4.5任意单位,肺动脉瓣为14.5±4.7任意单位(P=0.27)。
  • 男性血清对肺动脉去细胞同种瓣膜抗体结合均值17.2±4.2任意单位,显著高于女性的11.7±5.3任意单位(P=0.036)。
  • 对照血清与去细胞同种瓣膜ABO血型不合对抗体结合无影响,去细胞同种瓣膜供者年龄无影响。

临床怎么用

  • 斑点印迹法可半定量评估个体对去细胞同种瓣膜细胞外基质成分的免疫反应,或为术前同种瓣膜配型提供可能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Decellularized homograft valves (DHVs) have shown promising clinical results, particularly in the treatment of congenital heart disease. However, DHV appears to elicit an immune response in a subset of young patients, indicated by early valve degeneration. As the decellularization process is quality controlled for each DHV, we hypothesized that there may be residual immunogenicity within the extracellular matrix of DHV. METHODS: A semi-quantitative dot blot analysis was established to screen for preformed recipient antibodies using secondary anti-human antibodies. Fifteen DHV samples (7 aortic, 8 pulmonary) were solubilized and exposed to serum from 20 healthy controls. RESULTS: The sera from young controls (n = 10, 18-25 years) showed significantly stronger binding of preformed antibodies than sera from older individuals (n = 10, 48-73 years). The difference between the means of arbitrary units was 15.1 ± 6.5 (P = 0.0315). There was high intraindividual variance in the mean amounts of arbitrary units of antibody binding with some healthy controls showing >10 times higher antibody binding towards 2 different DHV. The amount of preformed antibodies bound to DHVs was higher in aortic than in pulmonary DHVs. The mean number of antibody binding (in arbitrary units) was 17.2 ± 4.5 in aortic and 14.5 ± 4.7 in pulmonary DHV (P = 0.27). The amount of preformed antibodies bound to pulmonary DHVs was statistically significantly higher in the sera of healthy males (n = 10) than in the sera of healthy females (n = 10). The mean number of arbitrary units was 17.2 ± 4.2 in male and 11.7 ± 5.3 in female sera (P = 0.036). Antibody binding to aortic DHV was also higher in males, but not significant (18.8 ± 5.0 vs 15.6 ± 4.0). Blood group (ABO) incompatibility between the serum from controls and DHV showed no impact on antibody binding, and there was no age-related impact among DHV donors. CONCLUSIONS: Residual immunogenicity of decellularized homografts appears to exist despite almost complete cell removal. The established dot blot method allows a semi-quantitative assessment of the individual immune response towards extracellular DHV components and potentially the possibility of preoperative homograft matching.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Ebken J, Mester N, Smart I, et al. Residual immune response towards decellularized homografts may be highly individual. Eur J Cardiothorac Surg. 2021. PMID: 33544830. doi:10.1093/ejcts/ezaa393

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。